Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hepatitis D

and liver cancer may ensue from Hepatitis D.Hepatitis D is a disease caused by a small circular RNA virus . HDV is considered to be a subviral satellite because it can propagate only in the presence of another virus, the hepatitis B virus . Transmission of HDV can occur either via simultaneous infection with HBV or via infection of an individual previously infected with HBV . Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%. and liver cancer may ensue from Hepatitis D.Hepatitis D is a disease caused by a small circular RNA virus . HDV is considered to be a subviral satellite because it can propagate only in the presence of another virus, the hepatitis B virus . Transmission of HDV can occur either via simultaneous infection with HBV or via infection of an individual previously infected with HBV . Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%. (From the Wikpedia article Hepatitis D.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hepatitis D:

Pubmed Logo
Hepatitis D: Scenario in the Asia-Pacific region.
Hepatitis D virus (HDV) infection is present worldwide and affects all age...
4th February, 2010
Department of Hepatogastroenterology, Sindh Institute of Urology and World J Gastroenterol. 2010 Feb 7;16(5):554-62.
Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.
OBJECTIVE: To determine the frequency of super infection of hepatitis C...
30th January, 2010
Department of Biochemistry, Ziauddin Medical College, Ziauddin University, J Coll Physicians Surg Pak. 2009 Nov;19(11):699-703.
DOI Direct Link
HBV genotype C is independently associated with cirrhosis in community-based population.
AIM: To determine the association of hepatitis B virus (HBV) genotypes...
19th January, 2010
Department of Epidemiology, Second Military Medical University, 800 World J Gastroenterol. 2010 Jan 21;16(3):379-83.
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.
Hepatitis D is caused by infection with the hepatitis D virus (HDV) and is...
7th January, 2010
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):31-40.
DOI Direct Link
Simultaneous determination of five-type hepatitis virus antigens in 5min using an integrated automatic electrochemical immunosensor array.
An integrated automatic electrochemical immunosensor array has been...
22nd December, 2009
Key Laboratory of Analysis and Detection for Food Safety (Ministry of Biosens Bioelectron. 2009 Dec 6.
DOI Direct Link

View more research publications.

Press Releases About Hepatitis D:

BioPortfolio Logo
Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 9th February, 2010 Debiopharm Group
LAUSANNE, Switzerland, February 9 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs
More Than 175 Public Health Organizations Send Letter of Support for Health Reform to Congress and the President 4th February, 2010 Trust for America's Health
WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- More than 175 organizations issued a letter of support today to the President, the U.S. Senate and U.S. House of Representatives to strongly support
/C O R R E C T I O N -- National Viral Hepatitis Roundtable/ 4th February, 2010 National Viral Hepatitis Roundtable
In the news release, NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap for Viral Hepatitis Education, Screening Programs, issued 04-Feb-2010 by National Viral Hepatitis
NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap for Viral Hepatitis Education, Screening Programs 4th February, 2010 National Viral Hepatitis Roundtable
WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each
'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 3rd February, 2010 Pharmaceutical Research and Manufacturers of America
WASHINGTON, Feb. 3 /PRNewswire-USNewswire/ -- Basketball great Alonzo Mourning will be featured on February's episode of Sharing Miracles - a 30-minute public affairs television program that

BioNews Results for Hepatitis D:

RSS Logo
BioPortfolio Logo
Achillion Pharma Out-Licensed China Rights for HIV, Hepatitis Treatment
Seeking Alpha:  Feb 4 2010 1:40PM Matching: hepatitis d
Achillion Pharmaceuticals Inc. (ACHN) Announces Lead Candidate for Hepatitis C Treatment
International Business Times:  Feb 1 2010 5:57PM Matching: hepatitis d
Management of Depression During Hepatitis C Treatment with Interferon-based Therapy
HIV and Hepatitis.com:  Jan 29 2010 3:30AM Matching: hepatitis d
Anadys Pharmaceuticals Provides Progress Update on Phase II Study of ANA598 in Hepatitis C Patients
Pharma Live:  Jan 24 2010 10:56PM Matching: hepatitis d
Anadys Pharmaceuticals Provides Progress Update on Phase II Study of ANA598 in Hepatitis C Patients
companiesandmarkets.com:  Jan 23 2010 7:53AM Matching: hepatitis d
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hepatitis D Clinical Trials:

Clinical Trials Logo
Pegylated Interferon to Treat Chronic Hepatitis D

Hepatitis D Patents:

USPTO Logo
US Patent No.Title
7514079 Antibodies that specifically bind to neurokinin B
7572640 Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
7579324 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
7579451 Oligonucleotides comprising a modified or non-natural nucleobase
7582450 Polynucleotide encoding an IL-29 polypeptide

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hepatitis D scientists - we have details of around 193 individuals working on Hepatitis D .


This page has been viewed 601 times
Recent Search Terms used to find this page: PDF HEPATITIS D | mortality hepatitis d | hepatitis d death rate | hepatitis-d genotype | 3649 hepatitis c | hepatitis d reports | hepatitis d mortality rate | SPC 3649 hepatite | morbidity and mortality of hepatitis d | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hepatitis D across BioPortfolio, or for Hepatitis D Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.